STORY AT-A-GLANCE (Limited Time Post from Mercola.com)

In the early 2000s, David Martin, Ph.D., founder of M-CAM International, started finding large numbers of patents that violate biological and chemical weapons laws.

In 1999, Dr. Anthony Fauci funded research to create “an infectious replication-defective recombinant coronavirus.” In 2002, Ralph Baric, Ph.D. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak.

Since 1999, at least 4,000 patents involving coronavirus have been filed, including patents detailing key features of the so-called “novel” SARS-CoV-2 virus.

The 2001 anthrax attack, which came out of medical and defense research, led to the passage of the PREP Act, which removed liability for manufacturers of emergency medical countermeasures.

The funds for entitlement programs and pensions will dry up by 2028, at which point the drug industry will go bankrupt as well. With a burgeoning population that is sick from the COVID jabs, we need to prepare new systems to care for each other.

In this interview, we continue our coverage of the COVID “plandemic” by speaking to David Martin, Ph.D., who has done a phenomenal job uncovering the paper trail behind the virus now known as SARS-CoV-2. As it turns out, this is not a novel virus at all, as patents and government grants detailing key features of the virus go back two decades.

Martin finished his doctorate at the University of Virginia in 1995, after which he was hired on to the medical school faculty in radiology and orthopedic surgery. In 2006, he set up the first medical device clinical trials organization for the University of Virginia — a company called IDEAmed — which conducted medical device clinical trials for U.S. Food and Drug Administration submission. So, he has an extensive background working with FDA clinical trials.

Monitoring Biological Weapons Violations
In 1998, he founded another company called M-CAM International, which is focused on finding ways to bring intellectual property into conventional finance. M-CAM also started auditing the U.S. patent system at the request of the U.S. Congress.

“Quite alarmingly, we found an enormous number of patents [detailing] biological and chemical weapon violations,” Martin says. “That was not something we were looking for. I let people know this was not something we set out to find. This is something that landed in our lap.

So, when you find a patent, for example, on a blast-resistant pathogen from a rocket-propelled grenade — did you hear what I just said? ‘A blast-resistant pathogen from a rocket-propelled grenade.’ Does that sound like it's a common way to inoculate a population or does that sound like [a bioweapon]?

And so, finding a number of bioweapons patents, we started taking into account some very serious things. I published once a year the literal global phonebook of every biological and chemical weapon violation that took place anywhere in the world.

In 2002, Ralph Baric, Ph.D. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak.

For more background on Fauci, be sure to read Robert F. Kennedy Jr.’s book “The Real Tony Fauci,” which details how Fauci’s promotion of AZT during the 1980s ended up killing hundreds of thousands of people. And the pattern we’re seeing with coronavirus is basically a repeat of previous behavior. Martin says:

Racketeering and Organized Crime

The biggest alarm bell was published February 12, 2016, by EcoHealth Alliance president Peter Daszak1 who, according to Martin, has been “the money laundering agent” for gain-of-function research coronaviruses after the U.S. implemented a moratorium on that kind of research in 2014. Rather than close it down, this research was simply moved over to China instead. In 2015, Daszak stated:

"To sustain the funding base beyond the crisis, we need to increase the public understanding of the need for medical countermeasures, such as a pan influenza or a pan coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of the process."

That statement was made by Daszak in 2015, and was published in the spring of 2016. The statement “set off alarm bells very loudly within my organization,” Martin says, “because when you have somebody who is promoting gain-of-function research, and clearly blurring the line on what is even legal … saying we need ‘media to create the hype’ … and ‘investors will follow if they see profit’ … that doesn't sound like public health.

To me, that sounds like organized crime. That sounds like racketeering, and we need to raise this issue.”